Wild Bactrian Camel Conservation

The wild Bactrian camel (Camelus bactrianus ferus) is critically endangered throughout its range in China and Mongolia. Yet, wild camels remain poorly understood, with knowledge derived primarily from a few short studies and anecdotal information. We initiated a wild camel conservation project to determine the reasons for camel decline and to develop a program to address those problems. We are employing satellite telemetry to gather data on wild camel movement patterns, home ranges, habitat use, and sources of mortality. We are also collecting feces from camels and wolves to determine important forage plants and to begin to assess predation levels, respectively. In addition, steroid fecal analysis may help us evaluate wild camel reproductive physiology. Finally, we are directly observing wild camels to study their behavior. Thus far, we successfully collared two wild camels (one male, one female). We received one year’s data on the cow before her Doppler satellite collar failed and are receiving only sporadic data from the GPS satellite collar on the bull. Over one year, the cow covered a minimum distance of 4,527 km and her 100% minimum convex polygon (MCP) home range was 17,232 km2. Her kernel home range sizes covered 8,696 km2 for 95%, 4,031 km2 for 75%, 2,284 km2 for 55%, and 612 km2 for 25% kernels. We received only 20 GPS locations on our bull from October 10, 2003 to March 22, 2004. During that time, he travelled a minimum of 683 km and his 100% MCP home range extended over 9,191 km2. His kernel home ranges covered 7,255 km2 for the 95%, 3,741 km2 for the 75%, 1,346 km2 for the 50%, 585 km2 for the 25%, and 115 km2 for the 5% kernel. Over the past few autumns, mean group size was 10.07±1.82 wild camels/group. We are currently analyzing the behavioral data and plan to evaluate the fecal samples once we have sufficient samples. We hope to use the knowledge derived from our work to develop a proactive conservation program working in close cooperation with the Mongolian government and other scientists and conservationists

Growing up with cancer: Accommodating the effects of cancer into young people’s social lives.

Adolescence and young adulthood are transitional periods of rapid and dramatic personal change. Few events can cause as unpredictable and challenging alterations to this process as the onset of a serious illness, such as cancer. Although we know much about the physical and psychological consequences of having cancer at this time, we know little about the effect of cancer on young people’s relationships. We conducted interviews with 15 women and 12 men aged between 16 and 29 years, who had survived cancer. Our findings demonstrate that the experience of cancer and how it affects relationships is complex. It arrests young people’s development by increasing their dependence on parents, giving them life experiences unavailable to peers, and complicating the process of establishing new relationships. However, it also accelerates development by facilitating closer and more mature relationships with parents and giving young people wisdom and insight not shared by peers. Cancer profoundly shapes how young people conduct their relationships. These changes require ongoing accommodation by young people with cancer, their parents, peers, and new acquaintances

Genomic diversity of bacteriophages infecting Microbacterium spp

The bacteriophage population is vast, dynamic, old, and genetically diverse. The genomics of phages that infect bacterial hosts in the phylum Actinobacteria show them to not only be diverse but also pervasively mosaic, and replete with genes of unknown function. To further explore this broad group of bacteriophages, we describe here the isolation and genomic characterization of 116 phages that infect Microbacterium spp. Most of the phages are lytic, and can be grouped into twelve clusters according to their overall relatedness; seven of the phages are singletons with no close relatives. Genome sizes vary from 17.3 kbp to 97.7 kbp, and their G+C% content ranges from 51.4% to 71.4%, compared to ~67% for their Microbacterium hosts. The phages were isolated on five different Microbacterium species, but typically do not efficiently infect strains beyond the one on which they were isolated. These Microbacterium phages contain many novel features, including very large viral genes (13.5 kbp) and unusual fusions of structural proteins, including a fusion of VIP2 toxin and a MuF-like protein into a single gene. These phages and their genetic components such as integration systems, recombineering tools, and phage-mediated delivery systems, will be useful resources for advancing Microbacterium genetics

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

\u3ci\u3eSorta Situ\u3c/i\u3e: The New Reality of Management Conditions for Wildlife Populations in the Absence of Wild Spaces

The rate of species loss today is approaching catastrophic levels. Scientists project that over the next two decades, more than 1 million species of plants and animals will become extinct. E.O. Wilson has estimated that the rate ofloss may exceed 50,000 a year, 137 a day ... this rate, while horrendous, is actually the minimal estimate, based on the species/area relationship alone (Kellert and Wilson 1993, p. 16; Aguirre 2009). Ever-expanding communities, strained natural resources, changes in land use, and other anthropogenic drivers are compromising ecosystems and rapidly changing the landscape and the availability of wild spaces

Clinical Course of Patients in Cardiogenic Shock Stratified by Phenotype.

BACKGROUND: Cardiogenic shock (CS) patients remain at 30% to 60% in-hospital mortality despite therapeutic innovations. Heterogeneity of CS has complicated clinical trial design. Recently, 3 distinct CS phenotypes were identified in the CSWG (Cardiogenic Shock Working Group) registry version 1 (V1) and external cohorts: I, noncongested; II, cardiorenal; and III, cardiometabolic shock. OBJECTIVES: The aim was to confirm the external reproducibility of machine learning-based CS phenotypes and to define their clinical course. METHODS: The authors included 1,890 all-cause CS patients from the CSWG registry version 2. CS phenotypes were identified using the nearest centroids of the initially reported clusters. RESULTS: Phenotypes were retrospectively identified in 796 patients in version 2. In-hospital mortality rates in phenotypes I, II, III were 23%, 41%, 52%, respectively, comparable to the initially reported 21%, 45%, and 55% in V1. Phenotype-related demographic, hemodynamic, and metabolic features resembled those in V1. In addition, 58.8%, 45.7%, and 51.9% of patients in phenotypes I, II, and III received mechanical circulatory support, respectively (P = 0.013). Receiving mechanical circulatory support was associated with increased mortality in cardiorenal (odds ratio [OR]: 1.82 [95% CI: 1.16-2.84]; P = 0.008) but not in noncongested or cardiometabolic CS (OR: 1.26 [95% CI: 0.64-2.47]; P = 0.51 and OR: 1.39 [95% CI: 0.86-2.25]; P = 0.18, respectively). Admission phenotypes II and III and admission Society for Cardiovascular Angiography and Interventions stage E were independently associated with increased mortality in multivariable logistic regression compared to noncongested stage C CS (P \u3c 0.001). CONCLUSIONS: The findings support the universal applicability of these phenotypes using supervised machine learning. CS phenotypes may inform the design of future clinical trials and enable management algorithms tailored to a specific CS phenotype

Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock

BACKGROUND: Heart failure-related cardiogenic shock (HF-CS) remains an understudied distinct clinical entity. OBJECTIVES: The authors sought to profile a large cohort of patients with HF-CS focused on practical application of the Society of Cardiovascular Angiography & Cardiovascular Interventions (SCAI) staging system to define baseline and maximal shock severity, in-hospital management with acute mechanical circulatory support (AMCS), and clinical outcomes. METHODS: The Cardiogenic Shock Working Group registry includes patients with CS, regardless of etiology, from 17 clinical sites enrolled between 2016 and 2020. Patients with HF-CS (non-acute myocardial infarction) were analyzed and classified based on clinical presentation, outcomes at discharge, and shock severity defined by SCAI stages. RESULTS: A total of 1,767 patients with HF-CS were included, of whom 349 (19.8%) had de novo HF-CS (DNHF-CS). Patients were more likely to present in SCAI stage C or D and achieve maximum SCAI stage D. Patients with DNHF-CS were more likely to experience in-hospital death and in- and out-of-hospital cardiac arrest, and they escalated more rapidly to a maximum achieved SCAI stage, compared to patients with acute-on-chronic HF-CS. In-hospital cardiac arrest was associated with greater in-hospital death regardless of clinical presentation (de novo: 63% vs 21%; acute-on-chronic HF-CS: 65% vs 17%; both P \u3c 0.001). Forty-five percent of HF-CS patients were exposed to at least 1 AMCS device throughout hospitalization. CONCLUSIONS: In a large contemporary HF-CS cohort, we identified a greater incidence of in-hospital death and cardiac arrest as well as a more rapid escalation to maximum SCAI stage severity among DNHF-CS. AMCS use in HF-CS was common, with significant heterogeneity among device types. (Cardiogenic Shock Working Group Registry [CSWG]; NCT04682483)